Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
BMC Cancer ; 14: 824, 2014 Nov 07.
Article in English | MEDLINE | ID: mdl-25380690

ABSTRACT

BACKGOUND: Oropharyngeal cancer (OPC) associated with human papilloma virus (HPV OPC) shows better treatment outcomes than non-HPV OPC. We investigated the expression of p53, ß-tubulin, bcl-2 and ERCC 1, which are well-known biomarkers to predict the chemotherapy response, according to HPV status in OPC patients. METHODS: Patients who treated with at least 2 cycles of induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced oropharyngeal cancer were reviewed. HPV PCR and immunohistochemical stain was done in paraffin embedded tumor tissue and evaluated the relation with the chemotherapy response and survival outcomes according to HPV status. RESULTS: Seventy-four patients were enrolled for this study and all patients received induction chemotherapy with docetaxel, 5-FU and cisplatin. After induction chemotherapy, complete response (CR) was shown in 22 patients (30%) and partial response (PR) in 46 patients (62%). HPV + was detected in 21 patients (28%), while 35 patients (47%) showed p16+ expression by IHC analysis. p16 positive patients showed better overall response, PFS and OS than p16 negative patients. p53 and class III beta-tubulin expression were significantly higher in HPV- and p16- than HPV + and p16+ patients. Conversely, bcl-2 expression was greater in HPV + or p16+ than HPV- or p16- patients. ERCC1 expression did not differ significantly according to HPV status. In multivariate analyses, early T stage (p = 0.036) and good PS (PS 0) (p = 0.029) showed a better 3Y-PFS rate, and low p53 expression (p = 0.012) and complete response after induction chemotherapy (p = 0.026) were highly associated with 3Y-OS rate. Low expression of p53 and p16 positive patients showed significantly prolonged OS than others (p = 0.010). CONCLUSION: P53, class III beta-tubulin and bcl-2 were differently expressed in OPC according to HPV status and present study suggested the underlying mechanism of better response to chemotherapy in case of HPV OPC than non-HPV OPC. Among these biomarkers, p53 is the strongest prognostic marker in OPC and p53 in addition to p16 support the rationale to study of de-escalation strategy for OPC.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/metabolism , Oropharyngeal Neoplasms/drug therapy , Oropharyngeal Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/genetics , Combined Modality Therapy , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Endonucleases/genetics , Endonucleases/metabolism , Female , Humans , Male , Middle Aged , Neoplasm Grading , Neoplasm Staging , Oropharyngeal Neoplasms/mortality , Oropharyngeal Neoplasms/pathology , Oropharyngeal Neoplasms/virology , Papillomaviridae/genetics , Papillomavirus Infections/virology , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Risk Factors , Treatment Outcome , Tubulin/genetics , Tubulin/metabolism , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
2.
J Endod ; 39(6): 801-5, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23683282

ABSTRACT

INTRODUCTION: Mineral trioxide aggregate (MTA) can induce differentiation of the dental pulp cells into odontoblast-like cells and generate a dentin-like mineral structure. The mechanisms underlying MTA-induced odontoblastic differentiation in human dental pulp cells (HDPCs) are not completely understood. The purpose of this study was to evaluate the effect of nifedipine as calcium channel blocker on MTA-induced odontoblastic differentiation in HDPCs. METHODS: HDPCs extracted from maxillary supernumerary incisors and third molars were directly cultured on MTA with or without nifedipine in the culture medium. Cell growth and expression of odontoblastic differentiation markers were determined by using methyl-thiazol-diphenyl-tetrazolium assay and reverse transcription-polymerase chain reaction analysis, respectively. Phosphorylation of mitogen-activated protein kinase was measured by Western blotting, and calcium deposition was assessed by using alizarin red S staining. RESULTS: MTA at a concentration of 1 mg/mL significantly up-regulated the expression of dentin sialophosphoprotein and dentin matrix protein-1 and enhanced mineralized nodule formation. However, nifedipine attenuated the MTA-induced odontoblastic differentiation in HDPCs. In addition, MTA-induced mineralization was blocked by inhibition of extracellular signal-regulated kinase (ERK), p38, and Jun N-terminal kinase (JNK) by using U0126, SB203580, and SP600125, respectively. Furthermore, phosphorylation of ERK and JNK in response to MTA was inhibited when the medium was supplemented with nifedipine. CONCLUSIONS: This study showed that calcium ions released from MTA play an important role in odontoblastic differentiation of HDPCs via modulation of ERK and JNK activation.


Subject(s)
Aluminum Compounds/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Compounds/pharmacology , Dental Pulp/drug effects , Nifedipine/pharmacology , Oxides/pharmacology , Root Canal Filling Materials/pharmacology , Silicates/pharmacology , Adult , Anthracenes/pharmacology , Butadienes/pharmacology , Calcium/analysis , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Culture Media , Dental Pulp/cytology , Drug Combinations , Extracellular Matrix Proteins/analysis , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Humans , Imidazoles/pharmacology , JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/analysis , Nitriles/pharmacology , Odontoblasts/drug effects , Phosphoproteins/analysis , Pyridines/pharmacology , Sialoglycoproteins/analysis , Tooth Calcification/drug effects , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
3.
J Microbiol ; 50(1): 137-42, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22367948

ABSTRACT

While it is generally accepted that Propionibacterium acnes is involved in the development of acne, other bacteria including Staphylococcus epidermidis have also been isolated from the acne lesion. The interaction between Lactobacillus reuteri, a probiotic bacterium, and acnegenic bacteria is unclear. This study examined the effects of L. reuteri on the proliferation of P. acnes and S. epidermidis. Human-derived L. reuteri strains (KCTC 3594 and KCTC 3678) and rat-derived L. reuteri KCTC 3679 were used. All strains exhibited significant inhibitory effects on the growth of P. acnes and S. epidermidis. The proliferation of P. acnes was decreased by 2-log scales after incubation with L. reuteri for 24 h. In addition, the proliferation of S. epidermidis was decreased by 3-log scales after incubation with L. reuteri for 24 h, whereas the growth of L. reuteri was unaffected by P. acnes or S. epidermidis. Among the L. reuteri strains examined, L. reuteri KCTC 3679 had the strongest inhibitory effect on the growth of P. acnes and S. epidermidis, followed by L. reuteri KCTC 3594 and L. reuteri KCTC 3678. Interestingly, reuterin, an antimicrobial factor, was produced only by L. reuteri KCTC 3594. The most pronounced the antibacterial activities of L. reuteri were attributed to the production of organic acids. Overall, these results suggest that L. reuteri may be a useful probiotic agent to control the growth of bacteria involved in acne inflammation and prevent acne.


Subject(s)
Antibiosis , Limosilactobacillus reuteri/physiology , Propionibacterium acnes/growth & development , Staphylococcus epidermidis/growth & development , Animals , Anti-Bacterial Agents/metabolism , Humans , Limosilactobacillus reuteri/growth & development , Limosilactobacillus reuteri/isolation & purification , Limosilactobacillus reuteri/metabolism , Microbial Viability , Rats
4.
Chonnam Med J ; 48(3): 159-63, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23323221

ABSTRACT

Daily use of probiotic chewing gum might have a beneficial effect on oral health, and it is important that the viability of the probiotics be maintained in this food product. In this study, we examined the stability of probiotic chewing gum containing Weissella cibaria. We evaluated the effects of various factors, including temperature and additives, on the survival of freeze-dried probiotic W. cibaria powder. No changes in viability were detected during storage at 4℃ for 5 months, whereas the viability of bacteria stored at 20℃ decreased. The stability of probiotic chewing gum decreased steadily during storage at 20℃ for 4 weeks. The viability of the freeze-dried W. cibaria mixed with various additives, such as xylitol, sorbitol, menthol, sugar ester, magnesium stearate, and vitamin C, was determined over a 4-week storage period at 20℃. Most of the freeze-dried bacteria except for those mixed with menthol and vitamin C were generally stable during a 3-week storage period. Overall, our study showed that W. cibaria was more stable at 4℃ than that at 20℃. In addition, menthol and vitamin C had a detrimental effect on the storage stability of W. cibaria. This is the first study to examine the effects of various chewing gum additives on the stability of W. cibaria. Further studies will be needed to improve the stability of probiotic bacteria for developing a novel probiotic W. cibaria gum.

5.
J Microbiol ; 49(2): 193-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21538238

ABSTRACT

The interaction between Lactobacillus reuteri, a probiotic bacterium, and oral pathogenic bacteria have not been studied adequately. This study examined the effects of L. reuteri on the proliferation of periodontopathic bacteria including Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas gingivalis, and Tannerella forsythia, and on the formation of Streptococcus mutans biofilms. Human-derived L. reuteri strains (KCTC 3594 and KCTC 3678) and rat-derived L. reuteri KCTC 3679 were used. All strains exhibited significant inhibitory effects on the growth of periodontopathic bacteria and the formation of S. mutans biofilms. These antibacterial activities of L. reuteri were attributed to the production of organic acids, hydrogen peroxide, and a bacteriocin-like compound. Reuterin, an antimicrobial factor, was produced only by L. reuteri KCTC 3594. In addition, L. reuteri inhibited the production of methyl mercaptan by F. nucleatum and P. gingivalis. Overall, these results suggest that L. reuteri may be useful as a probiotic agent for improving oral health.


Subject(s)
Antibiosis , Limosilactobacillus reuteri/physiology , Mouth/microbiology , Animals , Anti-Bacterial Agents/metabolism , Bacteroidetes/growth & development , Fusobacterium nucleatum/growth & development , Humans , Limosilactobacillus reuteri/metabolism , Pasteurellaceae/growth & development , Porphyromonas gingivalis/growth & development , Rats , Streptococcus mutans/growth & development
6.
J Microbiol ; 48(1): 40-3, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20221728

ABSTRACT

Zinc has antimicrobial activity and zinc salts including zinc chloride (ZnCl(2)) have been used for the control of oral malodor. In this study, we hypothesized that pyrrolidine dithiocarbamate (PDTC), a zinc ionophore, may enhance antimicrobial efficacy of ZnCl(2). The bactericidal effectiveness of ZnCl(2) alone (0.5-8 mM) or in combination with PDTC (1 or 10 microM) was evaluated by in vitro short (1 h) time-killing assays against Fusobacterium nucleatum and Porphyromonas gingivalis. Only a slight viability decrease was observed with ZnCl(2) or PDTC alone after 1-h incubation. By contrast, combination of ZnCl(2) and PDTC could achieve a more than 100-fold viability reduction compared with ZnCl(2) or PDTC alone in F. nucleatum and P. gingivalis. Therefore, PDTC greatly enhanced the bactericidal activity of ZnCl(2) against the oral malodor-producing bacteria. These results suggest that use of PDTC may be useful for enhancing bactericidal activity of antimalodor regimens of zinc salts.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chlorides/pharmacology , Pyrrolidines/pharmacology , Thiocarbamates/pharmacology , Zinc Compounds/pharmacology , Colony Count, Microbial , Drug Synergism , Fusobacterium nucleatum/drug effects , Fusobacterium nucleatum/growth & development , Microbial Sensitivity Tests , Microbial Viability/drug effects , Porphyromonas gingivalis/drug effects , Porphyromonas gingivalis/growth & development
7.
Cancer Lett ; 290(1): 68-75, 2010 Apr 01.
Article in English | MEDLINE | ID: mdl-19781850

ABSTRACT

(-)-Epigallocatechin-3-gallate (EGCG), a major green tea polyphenol, was tested for in vitro cytotoxicity against human laryngeal epidermoid carcinoma of the larynx Hep2 cells. EGCG-induced apoptotic cell death accompanied by a change in the cell cycle. However, EGCG did not result in caspase activation, nor did a caspase inhibitor block cell death. Furthermore, EGCG caused no change in the intracellular levels of reactive oxygen species (ROS). The levels of p53 were increased in the EGCG-treated cells, with a corresponding decrease in Bcl-2 and Bid protein levels as well as an increase in the Bax level. In addition, EGCG induced the cytoplasmic release of cytochrome c from the mitochondria accompanied by a decreased mitochondrial membrane potential, and subsequently upregulated translocation of apoptosis-inducing factor (AIF) and endonuclease G (EndoG) into the nucleus during the apoptotic process. Taken together, these findings indicate that the p53-mediated mitochondrial pathway and the nuclear translocation of AIF and EndoG play a crucial role in EGCG-induced apoptosis of human laryngeal epidermoid carcinoma Hep2 cells, which proceeds through a caspase-independent pathway.


Subject(s)
Anticarcinogenic Agents/pharmacology , Apoptosis Inducing Factor/metabolism , Carcinoma, Squamous Cell/metabolism , Catechin/analogs & derivatives , Endodeoxyribonucleases/metabolism , Laryngeal Neoplasms/metabolism , Apoptosis Inducing Factor/drug effects , Blotting, Western , Catechin/pharmacology , Cell Cycle/drug effects , Cell Line, Tumor , Endodeoxyribonucleases/drug effects , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Protein Transport/drug effects , Proto-Oncogene Proteins c-bcl-2/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/metabolism , Tumor Suppressor Protein p53/drug effects , Tumor Suppressor Protein p53/metabolism
8.
Am J Orthod Dentofacial Orthop ; 136(4): 564-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19815160

ABSTRACT

INTRODUCTION: The purpose of this study was to investigate the change of lip-line cant (LLC) after 1-jaw orthognathic surgery in mandibular asymmetry patients. METHODS: Preoperative and postoperative data of 22 patients having 1-jaw orthognathic surgery, with menton deviation over 2 degrees before the surgery, were our subjects. LLC was measured in the preoperative and postoperative frontal photographs, and its change was correlated with various craniofacial measurements obtained from preoperative and postoperative frontal cephalograms and maxillofacial 3-dimensional computed tomography images. RESULTS: Although these subjects had 2.4 degrees of LLC on average before surgery, LLC improved to 0.5 degrees after surgery, and the change (1.9 degrees ) was statistically significant. In the correlation analysis, preoperative LLC showed positive correlations with menton deviation and mandibular anterior occlusal plane cant. In the correlation analysis of LLC change, it had positive correlations with preoperative LLC and mandibular anterior occlusal plane cant and preoperative and postoperative change of menton deviation. CONCLUSIONS: These results suggest that LLC is present with chin deviation, even without significant maxillary canting, and can be improved considerably by 1-jaw surgery alone.


Subject(s)
Facial Asymmetry/surgery , Lip/pathology , Mandible/surgery , Cephalometry/methods , Chin/pathology , Dental Occlusion , Ear Canal/pathology , Eye/pathology , Facial Asymmetry/pathology , Female , Follow-Up Studies , Humans , Image Processing, Computer-Assisted/methods , Imaging, Three-Dimensional/methods , Male , Mandible/pathology , Maxilla/pathology , Nasal Bone/pathology , Orbit/pathology , Photography/methods , Tomography, X-Ray Computed/methods , Young Adult
9.
J Microbiol ; 47(6): 760-7, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20127471

ABSTRACT

Interactions between periodontal bacteria and human oral epithelial cells can lead to the activation and expression of a variety of inflammatory mediators in epithelial cells. Fusobacterium nucleatum is a filamentous human pathogen that is strongly associated with periodontal diseases. This study examined the effects of methyl gallate (MG) and gallic acid (GA) on the production of inflammatory mediators, interleukin (IL)-6 and IL-8, by oral epithelial cells stimulated by F. nucleatum. In a real-time reverse transcription-polymerase chain reaction and an enzyme-linked immunosorbent assay, live F. nucleatum induced high levels of gene expression and protein release of IL-6 and IL-8. The effects of MG and GA were examined by treating KB oral epithelial cells with MG and GA and stimulating them with F. nucleatum. MG and GA inhibited significantly the increases in the IL-6 and IL-8 gene and protein levels in a dose-dependent manner. These Compounds also inhibited the growth of F. nucleatum. No visible effects of MG and GA on the adhesion and invasion of KB cells by F. nucleatum were observed. In conclusion, both MG and GA inhibit IL-6 and IL-8 production from F. nucleatum-activated KB cells.


Subject(s)
Epithelial Cells/microbiology , Fusobacterium nucleatum/immunology , Gallic Acid/analogs & derivatives , Gallic Acid/pharmacology , Immunologic Factors/pharmacology , Interleukin-6/metabolism , Interleukin-8/metabolism , Cell Line , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/immunology , Gene Expression Profiling , Humans , Reverse Transcriptase Polymerase Chain Reaction
10.
Neurosci Lett ; 411(3): 222-7, 2007 Jan 16.
Article in English | MEDLINE | ID: mdl-17116366

ABSTRACT

Nitric oxide (NO) is associated with many pathophysiology of the central nervous system including brain ischemia, neurodegeneration and inflammation. Epigallocatechin gallate (EGCG) is a major compound of green tea polyphenol that has shown the protective activity against neuronal diseases. This study examined the effect of EGCG on NO-induced cell death in PC12 cells. The administration of sodium nitroprusside (SNP), a NO donor, decreased the cell viability and induced apoptosis showing characterization such as cell shrinkage and chromatin condensation as well as subG1 fraction of cell cycles. EGCG inhibited the cytotoxicity and apoptotic morphogenic changes induced by SNP. EGCG attenuated the production of reactive oxygen species (ROS) by SNP, and ameliorated the SNP-induced Bax to Bcl-2 expression ratio leading to apoptosis. In addition, EGCG prevented the release of cytochrome c from the mitochondria into the cytosol as well as the upregulation of the voltage-dependent anion channel (VDAC), a cytochrome c releasing channel, in the mitochondria of SNP-treated cells. EGCG abrogated the activation of caspase-9, caspase-8 and caspase-3 induced by SNP. These results demonstrate that EGCG has a protective effect against SNP-induced apoptosis in PC12 cells by scavenging ROS and modulating the signal molecules associated with cytochrome c, caspases, VDAC and the Bcl-2 family. These findings suggest that EGCG might be a natural neuroprotective substance.


Subject(s)
Antioxidants/pharmacology , Apoptosis/drug effects , Catechin/analogs & derivatives , Nitric Oxide/physiology , Animals , Blotting, Western , Caspases/metabolism , Catechin/pharmacology , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Gene Expression Regulation/drug effects , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , PC12 Cells/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Reactive Oxygen Species/metabolism , Tetrazolium Salts , Thiazoles , Time Factors , Voltage-Dependent Anion Channels/metabolism , bcl-2-Associated X Protein/metabolism
11.
Clin Diagn Lab Immunol ; 12(11): 1285-91, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16275942

ABSTRACT

Porphyromonas gingivalis is one of the suspected periodontopathic bacteria. The lipopolysaccharide (LPS) of P. gingivalis is a key factor in the development of periodontitis. Inflammatory cytokines play important roles in the gingival tissue destruction that is a characteristic of periodontitis. Macrophages are prominent at chronic inflammatory sites and are considered to contribute to the pathogenesis of periodontitis. Xylitol stands out and is widely believed to possess anticaries properties. However, to date, little is known about the effect of xylitol on periodontitis. The aim of the present study was to determine tumor necrosis factor alpha (TNF-alpha) and interleukin-1beta (IL-1beta) expression when RAW 264.7 cells were stimulated with P. gingivalis LPS (hereafter, LPS refers to P. gingivalis LPS unless stated otherwise) and the effect of xylitol on the LPS-induced TNF-alpha and IL-1beta expression. The kinetics of TNF-alpha and IL-1beta levels in culture supernatant after LPS treatment showed peak values at 1 h (TNF-alpha) and 2 to 4 h (IL-1beta), respectively. NF-kappaB, a transcription factor, was also activated by LPS treatment. These cytokine expressions and NF-kappaB activation were suppressed by pretreatment with pyrrolidine dithiocarbamate (an inhibitor of NF-kappaB). Pretreatment with xylitol inhibited LPS-induced TNF-alpha and IL-1beta gene expression and protein synthesis. LPS-induced mobilization of NF-kappaB was also inhibited by pretreatment with xylitol in a dose-dependent manner. Xylitol also showed inhibitory effect on the growth of P. gingivalis. Taken together, these findings suggest that xylitol may have good clinical effect not only for caries but also for periodontitis by its inhibitory effect on the LPS-induced inflammatory cytokine expression.


Subject(s)
Interleukin-1/antagonists & inhibitors , Interleukin-1/biosynthesis , Lipopolysaccharides/pharmacology , Porphyromonas gingivalis/immunology , Sweetening Agents/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/biosynthesis , Xylitol/pharmacology , Animals , Cariostatic Agents/pharmacology , Cell Line , Humans , Interleukin-1/genetics , Lipopolysaccharides/antagonists & inhibitors , Mice , NF-kappa B/metabolism , Porphyromonas gingivalis/drug effects , Porphyromonas gingivalis/growth & development , Tumor Necrosis Factor-alpha/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...